Table 2.
Polypharmacy score | Likelihood to cause harm | Ability to simplify | ||
---|---|---|---|---|
Total number of medicinesa | R | 0.92 | 0.68 | 0.67 |
P ‐value | <0.0001 | 0.002 | 0.002 | |
Beers criteria medicinesa | R | 0.39 | 0.69 | 0.50 |
P ‐value | 0.11 | 0.001 | 0.03 | |
STOPP criteria medicines | R | 0.45 | 0.34 | 0.59 |
P ‐value | 0.06 | 0.17 | 0.01 | |
Falls‐risk medicines | R | 0.54 | 0.67 | 0.58 |
P ‐value | 0.02 | 0.002 | 0.01 | |
Drug burden index | R | 0.57 | 0.68 | 0.57 |
P ‐value | 0.01 | 0.002 | 0.01 | |
Medicines causing postural hypotension | R | 0.42 | 0.28 | 0.16 |
P ‐value | 0.09 | 0.27 | 0.54 | |
Pharmacokinetic drug–drug interactions | R | 0.26 | 0.50 | 0.04 |
P ‐value | 0.29 | 0.04 | 0.87 |
Normally distributed data were examined using Pearson's correlation coefficient, and all other variables were examined using Spearman's correlation coefficient. Values highlighted in bold are statistically significant.